FR2381035A1 - Urees substituees utiles comme medicaments et procedes pour leur preparation - Google Patents

Urees substituees utiles comme medicaments et procedes pour leur preparation

Info

Publication number
FR2381035A1
FR2381035A1 FR7804270A FR7804270A FR2381035A1 FR 2381035 A1 FR2381035 A1 FR 2381035A1 FR 7804270 A FR7804270 A FR 7804270A FR 7804270 A FR7804270 A FR 7804270A FR 2381035 A1 FR2381035 A1 FR 2381035A1
Authority
FR
France
Prior art keywords
preparation
medicines
methods
substitutes useful
substitutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7804270A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2381035A1 publication Critical patent/FR2381035A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des urées substituées et leurs procédés de préparation. Elle concerne un composé ayant la formule :
FR7804270A 1977-02-17 1978-02-15 Urees substituees utiles comme medicaments et procedes pour leur preparation Withdrawn FR2381035A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/769,475 US4144338A (en) 1977-02-17 1977-02-17 N-pyrimidinyl-N-dialkylaminoalkyl ureas

Publications (1)

Publication Number Publication Date
FR2381035A1 true FR2381035A1 (fr) 1978-09-15

Family

ID=25085546

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7804270A Withdrawn FR2381035A1 (fr) 1977-02-17 1978-02-15 Urees substituees utiles comme medicaments et procedes pour leur preparation

Country Status (8)

Country Link
US (1) US4144338A (fr)
JP (1) JPS53103481A (fr)
DE (1) DE2806661A1 (fr)
ES (1) ES466844A1 (fr)
FR (1) FR2381035A1 (fr)
GB (1) GB1569517A (fr)
NL (1) NL7801064A (fr)
PT (1) PT67662B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215121A (en) * 1977-02-17 1980-07-29 Merck & Co., Inc. Pyrazine substituted ureas
US4415575A (en) * 1979-03-13 1983-11-15 Merck & Co., Inc. Suppression of gastric acid secretion using pyrimidylcarbamates
US4226871A (en) * 1979-03-13 1980-10-07 Merck & Co., Inc. Heterocyclic carbamates
US4235802A (en) * 1979-08-14 1980-11-25 E. I. Du Pont De Nemours And Company Propenimidates
US4619686A (en) * 1984-07-17 1986-10-28 Eli Lilly And Company Pyridazinylurea compounds and methods of use as herbicides
DE3531658A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
JPH0720943B2 (ja) * 1988-08-19 1995-03-08 宇部興産株式会社 アミノピリミジン誘導体、その製法及び殺虫・殺菌剤
DE4131924A1 (de) * 1991-09-25 1993-07-08 Hoechst Ag Substituierte 4-alkoxypyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
US7731985B2 (en) * 2002-03-15 2010-06-08 Ciba Specialty Chemicals Corporation 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759921A (en) * 1969-10-16 1973-09-18 Lilly Co Eli Method of suppressing immuneresponse with 1 substituted-3-(2 pyrimidyl)ureas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705159A (en) * 1970-03-05 1972-12-05 Sandoz Ltd Herbicidal 2,4-di(substituted) amino-6-chloro pyrimidines
US3950537A (en) * 1973-06-29 1976-04-13 Rohm And Haas Company Gastrointestinally active thioureas
US4008235A (en) * 1975-03-07 1977-02-15 Sterling Drug Inc. N-[2-(pyridinyl)-4-pyrimidinyl]ureas

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759921A (en) * 1969-10-16 1973-09-18 Lilly Co Eli Method of suppressing immuneresponse with 1 substituted-3-(2 pyrimidyl)ureas

Also Published As

Publication number Publication date
DE2806661A1 (de) 1978-08-31
PT67662A (en) 1978-03-01
ES466844A1 (es) 1979-08-16
PT67662B (en) 1980-03-03
JPS53103481A (en) 1978-09-08
NL7801064A (nl) 1978-08-21
US4144338A (en) 1979-03-13
GB1569517A (en) 1980-06-18

Similar Documents

Publication Publication Date Title
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
FR2365567A1 (fr) Nouvelles piperazinylpyridines utiles comme medicaments
FR2361370A1 (fr) Nouvelles pyridines substituees, leur preparation et leur application comme medicaments
FR2404626A1 (fr) Nouveaux derives a-halogenomethyles de l'acide g-aminobutyrique utiles comme medicaments et procedes de leur preparation
FR2381035A1 (fr) Urees substituees utiles comme medicaments et procedes pour leur preparation
FR2361346A1 (fr) Dipeptides utiles comme medicaments
FR2401148A1 (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
FR2392958A1 (fr) Nouveaux amino-acides fluores utiles comme medicament
FR2421914A1 (fr) 3-acetoxy-9b-11b-epoxy-pregna-trienes et dienes et procede de preparation de 6a-halogeno-pregna-1,4-diene-3 ones et de 6a halogeno-pregna-4-ene-3-ones correspondants
FR2361326A1 (fr) Derives de cyclohexane utiles comme agents odoriferants
FR2383950A1 (fr) Penicillines utilisables comme medicament
FR2374291A1 (fr)
FR2355011A1 (fr) 2-imino-3-aminothiazolidines utiles comme medicaments
FR2378792A1 (fr) Nouveaux esters et amides d'ester d'acides pyrimidinone-((di)-thio)-phosphoriques (phosphoniques) substitues, leur procede de preparation et leur application comme insecticides, acaricides et nematicides
FR2377997A1 (fr) Aralcoylanilines utilisables comme medicament
FR2443457A1 (fr) Derives de 1-phenyl-2-amino-1-propanol, leur procede de preparation et leur utilisation comme medicaments
FR2404001A1 (fr) Derives d'oxazolidone-2 utiles comme medicaments et procedes pour leur preparation
FR2385670A1 (fr) Procede de preparation de 2,2-dimethylolalcanals
FR2384771A1 (fr) Derives de quinazoline utiles comme medicament
FR2355846A1 (fr) Esters de penicillines utilisables comme medicaments
FR2401167A1 (fr) Derives de thienothiazine utiles comme medicaments
FR2442236A1 (fr)
FR2376135A1 (fr) Aminoethoxy-3 pyrrolidines substituees en position 1, utiles comme medi
FR2390422A1 (fr) Nouveaux 1-acyl-2-hydroxy-1,3-diaminopropanes, leur procede d'obtention et leur application comme medicaments
FR2433009A1 (fr) Procede pour la preparation de dicyclopentylene(2,2'-bis(4-alkyl-6-t-butylphenols))

Legal Events

Date Code Title Description
ST Notification of lapse